ABBV Fair Price
My Notes
Začít psátFeed
AbbVie (ABBV) - Attractive long-term investment from the healthcare sector
Why $ABBV is an interesting choice:
- The success of new drugs:
- Skyrizi and Rinvoq offset losses from Humira.
- Sales for Skyrizi up 48% and Rinvoq up 59%.
- Promising growth potential for$ABBV :
- The $10 billion acquisition of ImmunoGen and the planned $8.7 billion acquisition of Cerevel...
Read more
Healthcare sector, one of the most popular sectors for investors, especially value investors. What are we going to think, health is the one thing we should protect most in our lives, and companies that are involved in this will profit from it perhaps indefinitely. Thanks to them, our society is able to live to a ripe old age. who are your favourites in this sector? For me, I...
Read more
Charlie Munger and his view of healthcare in the US.
Charlie, a friend, partner of Warren, has recently been vocal about his concerns about US healthcare, literally stating that it is a system that prolongs death to make more money and comparing patients to African carcasses. 🤔
...Read more
For me, this is a very high quality company that last year and this year will reduce earnings per share. However, growth should return in the coming years. The dividend is also attractive. The potential for the future is certainly there.